Udvidelse af NHS Genomic Medicine Service åbner infrastrukturvindue - Vanguard Healthcare Solutions klar til at hjælpe

For trusts selected for significant capital investment, this shift presents both a challenge and an opportunity. They must not only upgrade buildings and clinical spaces but also integrate new pathways, data-driven diagnostics and flexible capacity that reflect the genomics era. This is where Vanguard Healthcare Solutions becomes a strategic partner.

Why this matters for trusts:

• The GMS infrastructure requires dedicated spaces for genomic diagnostics, science labs, specialised clinical consultation rooms, data-driven workflows and flexible clinical hubs.
• Estates renewal under the funding umbrella must account for these new service modalities
• Rapid deployment of modular infrastructure allows trusts to adapt for genomics-enabled pathways without deep disruption to existing services.

How Vanguard can support:

• Bespoke modular laboratory and clinical units built off-site, delivered with minimal disruption to operational services.
• Refurbishment and upgrade of existing estate to accommodate genomic diagnostic workflows, data-centric working and multidisciplinary consultation hubs.
• Flexible capacity modules (for example mobile clinical hubs) which can be deployed while the estate is under refurbishment, ensuring service continuity.
• End-to-end management: from business case development through design, delivery and commissioning, freeing trust estates and service leads to focus on clinical imperatives.

The moment to act is now.

With the NHS’s genomics strategy clearly codified (which aims to embed genomics across the care continuum, deliver equitable testing, leverage data and innovate research), trusts are under pressure to convert funding into fit-for-purpose, rapid-deployment infrastructure. Vanguard stands ready to support.

If your trust is one of those selected for this wave of investment - or planning to align its estate to the GMS agenda - get in touch with us at info@vanguardhealthcare.co.uk. Let’s convert genomic ambition into built, operational reality.